China · Delayed Price · Currency is CNY Boai NKY Medical Holdings Statistics
Total Valuation
SHE:300109 has a market cap or net worth of CNY 9.02 billion. The enterprise value is 8.65 billion.
| Market Cap | 9.02B |
| Enterprise Value | 8.65B |
Important Dates
The last earnings date was Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | Jul 10, 2025 |
Share Statistics
SHE:300109 has 483.38 million shares outstanding. The number of shares has increased by 0.36% in one year.
| Current Share Class | 483.38M |
| Shares Outstanding | 483.38M |
| Shares Change (YoY) | +0.36% |
| Shares Change (QoQ) | +4.15% |
| Owned by Insiders (%) | 18.19% |
| Owned by Institutions (%) | 4.29% |
| Float | 395.44M |
Valuation Ratios
The trailing PE ratio is 47.85.
| PE Ratio | 47.85 |
| Forward PE | n/a |
| PS Ratio | 7.66 |
| PB Ratio | 2.47 |
| P/TBV Ratio | 2.77 |
| P/FCF Ratio | 76.64 |
| P/OCF Ratio | 26.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.07, with an EV/FCF ratio of 73.48.
| EV / Earnings | 45.49 |
| EV / Sales | 7.34 |
| EV / EBITDA | 21.07 |
| EV / EBIT | 29.09 |
| EV / FCF | 73.48 |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.95 |
| Quick Ratio | 2.20 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.81 |
| Debt / FCF | 2.81 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 5.11% and return on invested capital (ROIC) is 7.05%.
| Return on Equity (ROE) | 5.11% |
| Return on Assets (ROA) | 4.25% |
| Return on Invested Capital (ROIC) | 7.05% |
| Return on Capital Employed (ROCE) | 7.72% |
| Weighted Average Cost of Capital (WACC) | 5.06% |
| Revenue Per Employee | 1.01M |
| Profits Per Employee | 163,444 |
| Employee Count | 1,163 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 1.84 |
Taxes
In the past 12 months, SHE:300109 has paid 50.66 million in taxes.
| Income Tax | 50.66M |
| Effective Tax Rate | 21.43% |
Stock Price Statistics
The stock price has increased by +30.37% in the last 52 weeks. The beta is 0.18, so SHE:300109's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | +30.37% |
| 50-Day Moving Average | 18.52 |
| 200-Day Moving Average | 17.82 |
| Relative Strength Index (RSI) | 54.87 |
| Average Volume (20 Days) | 10,654,663 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300109 had revenue of CNY 1.18 billion and earned 190.09 million in profits. Earnings per share was 0.39.
| Revenue | 1.18B |
| Gross Profit | 539.12M |
| Operating Income | 297.31M |
| Pretax Income | 236.41M |
| Net Income | 190.09M |
| EBITDA | 407.70M |
| EBIT | 297.31M |
| Earnings Per Share (EPS) | 0.39 |
Balance Sheet
The company has 715.64 million in cash and 330.58 million in debt, with a net cash position of 385.07 million or 0.80 per share.
| Cash & Cash Equivalents | 715.64M |
| Total Debt | 330.58M |
| Net Cash | 385.07M |
| Net Cash Per Share | 0.80 |
| Equity (Book Value) | 3.66B |
| Book Value Per Share | 7.71 |
| Working Capital | 1.01B |
Cash Flow
In the last 12 months, operating cash flow was 338.11 million and capital expenditures -220.42 million, giving a free cash flow of 117.69 million.
| Operating Cash Flow | 338.11M |
| Capital Expenditures | -220.42M |
| Depreciation & Amortization | 110.39M |
| Net Borrowing | -121.37M |
| Free Cash Flow | 117.69M |
| FCF Per Share | 0.24 |
Margins
Gross margin is 45.76%, with operating and profit margins of 25.24% and 16.14%.
| Gross Margin | 45.76% |
| Operating Margin | 25.24% |
| Pretax Margin | 20.07% |
| Profit Margin | 16.14% |
| EBITDA Margin | 34.61% |
| EBIT Margin | 25.24% |
| FCF Margin | 9.99% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 1.29%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 1.29% |
| Dividend Growth (YoY) | -75.07% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 68.03% |
| Buyback Yield | -0.36% |
| Shareholder Yield | 0.93% |
| Earnings Yield | 2.11% |
| FCF Yield | 1.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 7, 2024. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 7, 2024 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |